BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31865003)

  • 1. Elevated White Blood Cell Levels and Thrombotic Events in Patients With Polycythemia Vera: A Real-World Analysis of Veterans Health Administration Data.
    Parasuraman S; Yu J; Paranagama D; Shrestha S; Wang L; Baser O; Scherber R
    Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):63-69. PubMed ID: 31865003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between elevated white blood cell counts and thrombotic events in polycythemia vera: analysis from REVEAL.
    Gerds AT; Mesa R; Burke JM; Grunwald MR; Stein BL; Squier P; Yu J; Hamer-Maansson JE; Oh ST
    Blood; 2024 Apr; 143(16):1646-1655. PubMed ID: 38142448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematocrit levels and thrombotic events in patients with polycythemia vera: an analysis of Veterans Health Administration data.
    Parasuraman S; Yu J; Paranagama D; Shrestha S; Wang L; Baser O; Scherber R
    Ann Hematol; 2019 Nov; 98(11):2533-2539. PubMed ID: 31552445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematocrit, White Blood Cells, and Thrombotic Events in the Veteran Population With Polycythemia Vera.
    Tashi T
    Fed Pract; 2022 May; 39(Suppl 2):S43-S46. PubMed ID: 35929004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytoreductive treatment patterns among US veterans with polycythemia vera.
    Parasuraman S; Yu J; Paranagama D; Shrestha S; Wang L; Baser O; Scherber R
    BMC Cancer; 2018 May; 18(1):528. PubMed ID: 29728092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
    Lim Y; Lee JO; Kim SH; Kim JW; Kim YJ; Lee KW; Lee JS; Bang SM
    Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombotic complications of polycythemia vera.
    Varma S; Sharma A; Malhotra P; Kumari S; Jain S; Varma N
    Hematology; 2008 Dec; 13(6):319-23. PubMed ID: 19055858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Leone G; Barbui T;
    Am J Hematol; 2010 Feb; 85(2):97-100. PubMed ID: 20052743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera.
    Landolfi R; Di Gennaro L; Barbui T; De Stefano V; Finazzi G; Marfisi R; Tognoni G; Marchioli R;
    Blood; 2007 Mar; 109(6):2446-52. PubMed ID: 17105814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between leukocytosis and thrombosis in Philadelphia-negative chronic myeloproliferative neoplasms.
    Caramazza D; Caracciolo C; Barone R; Malato A; Saccullo G; Cigna V; Berretta S; Schinocca L; Quintini G; Abbadessa V; Di Raimondo F; Siragusa S
    Ann Hematol; 2009 Oct; 88(10):967-71. PubMed ID: 19214510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perspectives on thrombosis in essential thrombocythemia and polycythemia vera: is leukocytosis a causative factor?
    Barbui T; Carobbio A; Rambaldi A; Finazzi G
    Blood; 2009 Jul; 114(4):759-63. PubMed ID: 19372254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of JAK2V617F Mutation Burden on Disease Phenotype in Chinese Patients with JAK2V617F-positive Polycythemia Vera (PV) and Essential thrombocythemia (ET).
    Zhao S; Zhang X; Xu Y; Feng Y; Sheng W; Cen J; Wu D; Han Y
    Int J Med Sci; 2016; 13(1):85-91. PubMed ID: 26917989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors of long-term incidences of thrombosis, myelofibrosis and evolution into malignance in polycythemia vera: a single center experience from China.
    Bai J; Xue Y; Ye L; Yao J; Zhou C; Shao Z; Qian L; Yang R; Li H; Zhang H; Zheng Y
    Int J Hematol; 2008 Dec; 88(5):530-535. PubMed ID: 19002391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera.
    Gangat N; Wolanskyj AP; Schwager SM; Hanson CA; Tefferi A
    Cancer; 2009 Dec; 115(24):5740-5. PubMed ID: 19806641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leukocytosis in polycythemia vera and splenomegaly in essential thrombocythemia are independent risk factors for hemorrhage.
    Chou YS; Gau JP; Yu YB; Pai JT; Hsiao LT; Liu JH; Hong YC; Liu CY; Yang CF; Chen PM; Chiou TJ; Tzeng CH
    Eur J Haematol; 2013 Mar; 90(3):228-36. PubMed ID: 23281576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A dynamic prognostic model to predict survival in post-polycythemia vera myelofibrosis.
    Passamonti F; Rumi E; Caramella M; Elena C; Arcaini L; Boveri E; Del Curto C; Pietra D; Vanelli L; Bernasconi P; Pascutto C; Cazzola M; Morra E; Lazzarino M
    Blood; 2008 Apr; 111(7):3383-7. PubMed ID: 18187660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Overall survival and prognosis of patients with polycythemia vera: an analysis based on 906 patients from a single center].
    Liu D; Xu ZF; Zhang PH; Ma J; Qin TJ; Qu SQ; Sun XJ; Li B; Pan LJ; Jia YJ; Xiao ZJ
    Zhonghua Xue Ye Xue Za Zhi; 2021 Nov; 42(11):898-903. PubMed ID: 35045650
    [No Abstract]   [Full Text] [Related]  

  • 18. The Predictive Value of Neutrophil-Lymphocyte Ratio in Patients with Polycythemia Vera at the Time of Initial Diagnosis for Thrombotic Events.
    Wang X; Tu Y; Cao M; Jiang X; Yang Y; Zhang X; Lai H; Tu H; Li J
    Biomed Res Int; 2022; 2022():9343951. PubMed ID: 35978626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile of homozygous JAK2 617V>F mutation in patients with polycythemia vera or essential thrombocythemia.
    Vannucchi AM; Antonioli E; Guglielmelli P; Rambaldi A; Barosi G; Marchioli R; Marfisi RM; Finazzi G; Guerini V; Fabris F; Randi ML; De Stefano V; Caberlon S; Tafuri A; Ruggeri M; Specchia G; Liso V; Rossi E; Pogliani E; Gugliotta L; Bosi A; Barbui T
    Blood; 2007 Aug; 110(3):840-6. PubMed ID: 17379742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of hemostatic balance in blood from patients with polycythemia vera by means of thromboelastography: the effect of isovolemic erythrocytapheresis.
    Rusak T; Ciborowski M; Uchimiak-Owieczko A; Piszcz J; Radziwon P; Tomasiak M
    Platelets; 2012; 23(6):455-62. PubMed ID: 22098131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.